《大行報告》摩通下調港交所(00388.HK)目標價至540元 評級「增持」
摩根大通發表研究報告指,考慮到股票及衍生產品交易量下降,將港交所(00388.HK)2021至2023財年每股盈利預測下調5%至17%,分別達9.84、11.97及14.3元。
該行指出,內地經濟復甦,當局政策清晰,加上南向及北向交易情況改善,將推動中概股回歸潮,但認為部分政策和地緣政治變化可能會導致北向交易減少。摩通指,MSCI中國A50互聯互通指數回升速度明顯低於預期,亦導致該行對交易所的每股盈利預測下降。
摩通預期港交所2021至2023年每股盈利將複合增長22%,維持「增持」評級,基於45.9倍的動態市盈率,將目標價由580元下調至540元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.